{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:26:02Z","timestamp":1783124762210,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01960-5","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:02:05Z","timestamp":1762912925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A New Variant in CTLA4 Highlights the Heterogeneous Phenotype of CTLA4 Haploinsufficiency"],"prefix":"10.1007","volume":"45","author":[{"given":"Jonathan","family":"Sormani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaele","family":"Nove-Josserand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Rosain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Viel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Ouachee-Chardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Giannoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moskovtchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Rabeyrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Balme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"1960_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41576-023-00656-z","volume":"25","author":"YT Akalu","year":"2024","unstructured":"Akalu YT, Bogunovic D. Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat Rev Genet. 2024;25:184\u201395.","journal-title":"Nat Rev Genet"},{"key":"1960_CR2","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20:1410\u20136.","journal-title":"Nat Med"},{"key":"1960_CR3","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3389\/fimmu.2018.02012","volume":"9","author":"D Egg","year":"2018","unstructured":"Egg D, Schwab C, Gabrysch A, Arkwright PD, Cheesman E, Giulino-Roth L, et al. Increased risk for malignancies in 131 affected CTLA4 mutation carriers. Front Immunol. 2018;9:2012.","journal-title":"Front Immunol"},{"key":"1960_CR4","doi-asserted-by":"publisher","first-page":"e1560","DOI":"10.1212\/WNL.0000000000207609","volume":"101","author":"C Coustal","year":"2023","unstructured":"Coustal C, Goulabchand R, Labauge P, Guilpain P, Carra-Dalli\u00e8re C, Januel E, et al. Clinical, Radiologic, and Immunologic features of patients with CTLA4 deficiency with neurologic involvement. Neurology. 2023;101:e1560\u20136.","journal-title":"Neurology"},{"key":"1960_CR5","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","volume":"142","author":"C Schwab","year":"2018","unstructured":"Schwab C, Gabrysch A, Olbrich P, Pati\u00f1o V, Warnatz K, Wolff D, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4\u2013insufficient subjects. J Allergy Clin Immunol. 2018;142:1932\u201346.","journal-title":"J Allergy Clin Immunol"},{"key":"1960_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/cei.13600","volume":"205","author":"M Jamee","year":"2021","unstructured":"Jamee M, Hosseinzadeh S, Sharifinejad N, Zaki-Dizaji M, Matloubi M, Hasani M, et al. Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review. Clin Exp Immunol. 2021;205:28\u201343.","journal-title":"Clin Exp Immunol"},{"key":"1960_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10875-024-01831-5","volume":"45","author":"C Brakta","year":"2024","unstructured":"Brakta C, Tabet AC, Puel M, Pacault M, Stolzenberg MC, Goudet C, et al. 2q33 deletions underlying syndromic and Non-syndromic CTLA4 deficiency. J Clin Immunol. 2024;45:46.","journal-title":"J Clin Immunol"},{"key":"1960_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u20135.","journal-title":"Nat Genet"},{"key":"1960_CR9","doi-asserted-by":"crossref","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;Chap. 7:Unit7.20.","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"1960_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with alphafold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"1960_CR11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, et al. Variant interpretation using population databases: lessons from GnomAD. Hum Mutat. 2022;43:1012\u201330.","journal-title":"Hum Mutat"},{"key":"1960_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The human gene mutation database: Building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133:1\u20139.","journal-title":"Hum Genet"},{"key":"1960_CR13","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980\u20135.","journal-title":"Nucleic Acids Res"},{"key":"1960_CR14","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jaci.2023.08.004","volume":"152","author":"N Taghizade","year":"2023","unstructured":"Taghizade N, Babayeva R, Kara A, Karakus IS, Catak MC, Bulutoglu A, et al. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency. J Allergy Clin Immunol. 2023;152:1634\u201345.","journal-title":"J Allergy Clin Immunol"},{"key":"1960_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jcp.56.1.12","volume":"56","author":"P Kelleher","year":"2003","unstructured":"Kelleher P, Misbah SA. What is good\u2019s syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol. 2003;56:12\u20136.","journal-title":"J Clin Pathol"},{"key":"1960_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711\u201323.","journal-title":"N Engl J Med"},{"key":"1960_CR17","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/blood-2016-10-745174","volume":"129","author":"TZ Hou","year":"2017","unstructured":"Hou TZ, Verma N, Wanders J, Kennedy A, Soskic B, Janman D, et al. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. Blood. 2017;129:1458\u201368.","journal-title":"Blood"},{"key":"1960_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","volume":"128","author":"B Lo","year":"2016","unstructured":"Lo B, Fritz JM, Su HC, Uzel G, Jordan MB, Lenardo MJ. CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency. Blood. 2016;128:1037\u201342.","journal-title":"Blood"},{"key":"1960_CR19","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1080\/09273948.2023.2250441","volume":"32","author":"R Woodward","year":"2024","unstructured":"Woodward R, Gross A, Justin GA, Jaffe GJ, Grewal DS. Bilateral panuveitis in an adolescent with autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency. Ocul Immunol Inflamm. 2024;32:1888\u201392.","journal-title":"Ocul Immunol Inflamm"},{"key":"1960_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09273948.2019.1577978","volume":"28","author":"MM Sun","year":"2020","unstructured":"Sun MM, Levinson RD, Filipowicz A, Anesi S, Kaplan HJ, Wang W, et al. Uveitis in patients treated with CTLA-4 and PD-1 checkpoint Blockade Inhibition. Ocul Immunol Inflamm. 2020;28:217\u201327.","journal-title":"Ocul Immunol Inflamm"},{"key":"1960_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","volume":"149","author":"D Egg","year":"2022","unstructured":"Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, et al. Therapeutic options for CTLA-4 insufficiency. J Allergy Clin Immunol. 2022;149:736\u201346.","journal-title":"J Allergy Clin Immunol"},{"key":"1960_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1182\/blood.2021013496","volume":"139","author":"C Dhunputh","year":"2022","unstructured":"Dhunputh C, Ducassou S, Fernandes H, Picard C, Rieux-Laucat F, Viallard JF, et al. Abatacept is useful in autoimmune cytopenia with Immunopathologic manifestations caused by CTLA-4 defects. Blood. 2022;139:300\u20134.","journal-title":"Blood"},{"key":"1960_CR23","doi-asserted-by":"publisher","first-page":"e200351","DOI":"10.1212\/NXI.0000000000200351","volume":"12","author":"S Pfeuffer","year":"2025","unstructured":"Pfeuffer S, Nelke C, Pawlitzki M, Ruck T, Schroeter CB, Thomas C, et al. Abatacept induces Long-Term reconstitution of the B-Cell niche in a patient with CTLA-4 haploinsufficiency: A case report. Neurol Neuroimmunol Neuroinflamm. 2025;12:e200351.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1960_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/35069118","volume":"410","author":"CC Stamper","year":"2001","unstructured":"Stamper CC, Zhang Y, Tobin JF, Erbe DV, Ikemizu S, Davis SJ, et al. Crystal structure of the B7-1\/CTLA-4 complex that inhibits human immune responses. Nature. 2001;410:608\u201311.","journal-title":"Nature"},{"key":"1960_CR25","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3389\/fimmu.2019.01544","volume":"10","author":"OM Siggs","year":"2019","unstructured":"Siggs OM, Russell A, Singh-Grewal D, Wong M, Chan P, Craig ME, et al. Preponderance of CTLA4 variation associated with autosomal dominant immune dysregulation in the MYPPPY motif. Front Immunol. 2019;10:1544.","journal-title":"Front Immunol"},{"key":"1960_CR26","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/ccr3.1257","volume":"5","author":"MF Moraes-Fontes","year":"2017","unstructured":"Moraes-Fontes MF, Hsu AP, Caramalho I, Martins C, Ara\u00fajo AC, Louren\u00e7o F, et al. Fatal CTLA\u20104 heterozygosity with autoimmunity and recurrent infections: a de Novo mutation. Clin Case Rep. 2017;5:2066\u201370.","journal-title":"Clin Case Rep"},{"key":"1960_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ncprheum0624","volume":"3","author":"X Valencia","year":"2007","unstructured":"Valencia X, Lipsky PE. CD4\u2009+\u2009CD25\u2009+\u2009FoxP3\u2009+\u2009regulatory T cells in autoimmune diseases. Nat Rev Rheumatol. 2007;3:619\u201326.","journal-title":"Nat Rev Rheumatol"},{"key":"1960_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaut.2017.07.009","volume":"84","author":"RC Ferreira","year":"2017","unstructured":"Ferreira RC, Simons HZ, Thompson WS, Rainbow DB, Yang X, Cutler AJ, et al. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity. J Autoimmun. 2017;84:75\u201386.","journal-title":"J Autoimmun"},{"key":"1960_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.imlet.2023.03.003","volume":"255","author":"L Beckers","year":"2023","unstructured":"Beckers L, Somers V, Fraussen J. IgD\u2009\u2013\u2009CD27\u2009\u2013\u2009double negative (DN) B cells: origins and functions in health and disease. Immunol Lett. 2023;255:67\u201376.","journal-title":"Immunol Lett"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01960-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01960-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01960-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:45:56Z","timestamp":1777304756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01960-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01960-5","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}